<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03725319</url>
  </required_header>
  <id_info>
    <org_study_id>PSB Epiverstent 01</org_study_id>
    <nct_id>NCT03725319</nct_id>
  </id_info>
  <brief_title>Treatment of Post Sphincterotomy-bleeding by Epinephrine-injection Versus Insertion of an Plastic Stent</brief_title>
  <official_title>Retrospective Study on Treatment of Post Sphincterotomy-bleeding by Epinephrine-injection Versus Insertion of an Endoprosthesis: a Single Center Experience Over 16 Years With 5698 ERCPs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Theresienkrankenhaus und St. Hedwig-Klinik GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Theresienkrankenhaus und St. Hedwig-Klinik GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Post sphinterotomy-bleeding (PSB) occurs in 1-2 % of Endosocpic Retrograde
      Cholangiopancreaticography (ERCP) and usually needs no blood transfusion after endoscopic
      therapy but can be life-threatening in some rare cases.

      There are no prospective comparative studies concerning the endoscopic treatment of PSB due
      to the rarity of the incident.

      Insertion of an endoprosthesis in the common bile duct may be more effective than
      Epinephrin-injection into the papilla which is the therapy of first choice.

      A retrospective single centre analysis on both used methods over a study period of 16 years
      shall be performed.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Post sphinterotomy-bleeding (PSB) occurs in 1-2 % of Endosocpic Retrograde
      Cholangiopancreaticography (ERCP) and usually needs no blood transfusion after endoscopic
      therapy but can be life-threatening in some rare cases.

      The increasing use of antiplatelet and/or anticoagulant therapies enhances the risk of PSB.

      There are no prospective comparative studies concerning the endoscopic treatment of PSB due
      to the rarity of the incident.

      Insertion of an endoprosthesis in the common bile duct may be more effective than
      Epinephrin-injection into the papilla which is the therapy of first choice.

      A retrospective single centre analysis on both used methods over a study period of 16 years
      shall be performed.

      In detail, clinical success and safety of the procedure, re-bleeding rate, number of
      re-interventions and days of hospital stay will be analysed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 29, 2018</start_date>
  <completion_date type="Actual">December 15, 2018</completion_date>
  <primary_completion_date type="Actual">November 30, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical success</measure>
    <time_frame>From the successful endocopic treatment of post sphincterotomy-bleeding up to 30 days in the follow up</time_frame>
    <description>No re-bleeding occurs in the follow-up that requirers a further interventional treatment of re-bleeding (any endoscopic, radiological embolization or surgery): yes/no</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Re-interventions</measure>
    <time_frame>From the endoscopic treatment of post-sphincterotomy-bleeding up to three months</time_frame>
    <description>Amount of endoscopic re-interventions (further endoscopic therapy of re-bleeding of the papilla, removal or exchange of the plastic stent): number (n)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hospital stay after treatment</measure>
    <time_frame>From the endoscopic treatment of post-sphincterotomy-bleeding up to 30 days</time_frame>
    <description>Hospital stay (days) after treatment of post sphincterotomy-bleeding</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post ERCP-pancreatitis</measure>
    <time_frame>From the endoscopic treatment of post-sphincterotomy-bleeding up to three days</time_frame>
    <description>Any kind of post ERCP-pancreatitis that occurs after treatment of post sphincterotomy-bleeding and can be refered to this treatment (patients with cannulated pancreatic duct are excluded): yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Increasing of cholestasis parameters</measure>
    <time_frame>From treatment of post-sphincterotomy-bleeding up to three days</time_frame>
    <description>Any kind of cholestasis measured by an increase of bilirubin level (mg/dl) after the treatment of post-sphincterotomy-bleeding that can be refered to this treatment (patients with unsuccesful endoscopic drainage/stone extraction are excluded): yes/no</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">100</enrollment>
  <condition>Endoscopic Biliary Sphincterotomy</condition>
  <condition>Bleeding</condition>
  <arm_group>
    <arm_group_label>Epinephrin injection</arm_group_label>
    <description>Diluted Epinephrin (1:100) in small amounts from 1 to 5 ml is injected into apex of the papilla to stop post sphincterotomy-bleeding</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Plastic stent insertion</arm_group_label>
    <description>A plastic stent (diameter: 8-11,5F and length of 50 -100mm) is inserted into the common bile duct to stop post sphincterotomy-bleeding</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All documented ERCPs in the single centre institution database are systematically screened
        for post sphincterotomy-bleeding in the time period from 1.1.2002 to 29.10.2018
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Post sphincterotomy bleeding (PSB) of the papilla (time frame: from procedure up to
             ten days after the procedure)

          -  Treatment of PSB by epinephrine-injection or insertion of a plastic stent into the
             common bile duct

        Exclusion Criteria:

          -  Pregnant and/or lactating women

          -  Complete patient record is not available
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Schmitz, Dr.med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Theresienkrankenhaus und St.Hedwigsklinik GmbH, Bassermannstr.1, 68165 Mannheim</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Tertiary referral hospital: Theresienkrankenhaus und St. Hedwig Hospital, Academic</name>
      <address>
        <city>Mannheim</city>
        <zip>68165</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Andriulli A, Loperfido S, Napolitano G, Niro G, Valvano MR, Spirito F, Pilotto A, Forlano R. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007 Aug;102(8):1781-8. Epub 2007 May 17. Review.</citation>
    <PMID>17509029</PMID>
  </reference>
  <reference>
    <citation>Freeman ML, Nelson DB, Sherman S, Haber GB, Herman ME, Dorsher PJ, Moore JP, Fennerty MB, Ryan ME, Shaw MJ, Lande JD, Pheley AM. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996 Sep 26;335(13):909-18.</citation>
    <PMID>8782497</PMID>
  </reference>
  <reference>
    <citation>Cotton PB, Lehman G, Vennes J, Geenen JE, Russell RC, Meyers WC, Liguory C, Nickl N. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991 May-Jun;37(3):383-93. Review.</citation>
    <PMID>2070995</PMID>
  </reference>
  <reference>
    <citation>Matsushita M, Hajiro K, Takakuwa H, Nishio A. Effective hemostatic injection above the bleeding site for uncontrolled bleeding after endoscopic sphincterotomy. Gastrointest Endosc. 2000 Feb;51(2):221-3.</citation>
    <PMID>10650275</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 29, 2018</study_first_submitted>
  <study_first_submitted_qc>October 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 31, 2018</study_first_posted>
  <last_update_submitted>March 18, 2020</last_update_submitted>
  <last_update_submitted_qc>March 18, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Theresienkrankenhaus und St. Hedwig-Klinik GmbH</investigator_affiliation>
    <investigator_full_name>Daniel Schmitz</investigator_full_name>
    <investigator_title>Assistant medical director</investigator_title>
  </responsible_party>
  <keyword>Endoscopic Biliary Sphincterotomy</keyword>
  <keyword>Endoscopic Retrograde Cholangiopancreatography</keyword>
  <keyword>Bleeding</keyword>
  <keyword>Epinephrine</keyword>
  <keyword>Stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

